[1]Lin D W, Chang C C, Hsu Y C, et al. New insights into the treatment of glomerular diseases: when mechanisms become vivid[J]. Int J Mol Sci, 2022, 23(7): 3525.
[2]Sethi S, Fervenza F C. Standardized classification and reporting of glomerulonephritis[J]. Nephrol Dial Transplant, 2019, 34(2): 193-199.
[3]Murton M, Goff-Leggett D, Bobrowska A, et al. Burden of chronic kidney disease by KDIGO categories of glomerular filtration rate and albuminuria: a systematic review[J]. Adv Ther, 2021, 38(1): 180-200.
[4]Provenzano M, Coppolino G, Faga T R A, et al. Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer[J]. Rev Cardiovasc Med, 2019, 20(4): 209-220.
[5]Singh R, Bhalla K, Nanda S, et al. Correlation of spot urinary protein: Creatinine ratio and quantitative proteinuria in pediatric patients with nephrotic syndrome[J]. J Family Med Prim Care, 2019, 8(7): 2343-2346.
[6]Kobayashi S, Amano H, Terawaki H, et al. Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy[J]. BMC Nephrol, 2019, 20(1): 306.
[7]Kamińska J, Dymicka-Piekarska V, Tomaszewska J, et al. Diagnostic utility of protein to creatinine ratio (P/C ratio) in spot urine sample within routine clinical practice[J]. Crit Rev Clin Lab Sci, 2020, 57(5): 345-364.
[8]Di Meo A, Batruch I, Yousef A G, et al. An integrated proteomic and peptidomic assessment of the normal human urinome[J]. Clin Chem Lab Med, 2017, 55(2): 237-247.
[9]Makhammajanov Z, Kabayeva A, Auganova D, et al. Candidate protein biomarkers in chronic kidney disease: a proteomics study[J]. Sci Rep, 2024, 14(1): 14014.
[10]Chen C H, Wu H Y, Wang C L, et al. Proteinuria as a therapeutic target in advanced chronic kidney disease: a retrospective multicenter cohort study[J]. Sci Rep, 2016, 6: 26539.
[11]Watanabe M, Funabiki K, Tsuge T, et al. Using protein/creatinine ratios in random urine[J]. J Clin Lab Anal, 2005, 19(4): 160-166.
[12]Incir S, Tasdemir M, Kocak B, et al. Improving the urine spot protein/creatinine ratio by the estimated creatinine excretion to predict proteinuria in pediatric kidney transplant recipients[J]. Pediatr Transplant, 2021, 25(7): e14142.
[13]Feng P F, Wei D, Zhang Y J, et al. Comparison on the consistency of Mindray and Siemens chemiluminescence analyzers for detecting FT3, FT4 and TSH in patients with hyper- and hypothyroidism[J]. Ann Transl Med, 2022, 10(20): 1133.
[14]Ayosanmi O, Delbaere M, Taylor J. Development of a Propensity to Self-Medicate with Over-the-Counter Medicines Scale (PSM-OTC)[J]. Innov Pharm, 2022, 13(3): 1-10.
[15]Hexsel D, Valente-Bezerra I. Dal'forno T,et al. Buttocks' Skin Laxity Severity Scale[J]. Dermatol Surg, 2022, 48(6): 648-652.
[16]Dog∨an N Ö. Bland-Altman analysis: a paradigm to understand correlation and agreement[J]. Turk J Emerg Med, 2018, 18(4): 139-141.
[17]Giavarina D. Understanding bland altman analysis[J]. Biochem Med, 2015, 25(2): 141-151.
[18]Raza A, Nawaz S H, Rashid R, et al. The correlation of spot urinary protein-to-creatinine ratio with 24-h urinary protein excretion in various glomerulopathies[J]. World J Nephrol, 2023, 12(5): 159-167.
[19]Mohtashamian A, Mozaffari-Rad N, Soleimani A, et al. Dietary magnesium intake and proteinuria: is there a relationship?[J]. Biol Trace Elem Res, 2024, 202(9): 3959-3966.
|